In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis

被引:119
作者
Andes, D [1 ]
机构
[1] Univ Wisconsin, Dept Med, Infect Dis Sect, Madison, WI 53792 USA
关键词
D O I
10.1128/AAC.47.4.1179-1186.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1179 / 1186
页数:8
相关论文
共 38 条
[31]   INFLUENCE OF SERUM-PROTEIN BINDING ON THE IN-VITRO ACTIVITY OF ANTIFUNGAL AGENTS [J].
SCHAFERKORTING, M ;
KORTING, HC ;
RITTLER, W ;
OBERMULLER, W .
INFECTION, 1995, 23 (05) :292-297
[32]   Current and emerging azole antifungal agents [J].
Sheehan, DJ ;
Hitchcock, CA ;
Sibley, CM .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) :40-+
[33]   THE POSTANTIBIOTIC EFFECT OF ANTIFUNGAL AGENTS AGAINST COMMON PATHOGENIC YEASTS [J].
TURNIDGE, JD ;
GUDMUNDSSON, S ;
VOGELMAN, B ;
CRAIG, WA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (01) :83-92
[34]   COMPARISON OF THE EFFICACIES OF AMPHOTERICIN-B, FLUCONAZOLE, AND ITRACONAZOLE AGAINST A SYSTEMIC CANDIDA-ALBICANS INFECTION IN NORMAL AND NEUTROPENIC MICE [J].
VANTWOUT, JW ;
MATTIE, H ;
VANFURTH, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :147-151
[35]   CORRELATION OF ANTIMICROBIAL PHARMACOKINETIC PARAMETERS WITH THERAPEUTIC EFFICACY IN AN ANIMAL-MODEL [J].
VOGELMAN, B ;
GUDMUNDSSON, S ;
LEGGETT, J ;
TURNIDGE, J ;
EBERT, S ;
CRAIG, WA .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (04) :831-847
[36]  
Walsh TJ, 2000, J CLIN MICROBIOL, V38, P2369
[37]   EXPERIMENTAL ANTIFUNGAL CHEMOTHERAPY IN GRANULOCYTOPENIC ANIMAL-MODELS OF DISSEMINATED CANDIDIASIS - APPROACHES TO UNDERSTANDING INVESTIGATIONAL ANTIFUNGAL COMPOUNDS FOR PATIENTS WITH NEOPLASTIC DISEASES [J].
WALSH, TJ ;
LEE, JW ;
ROILIDES, E ;
FRANCIS, P ;
BACHER, J ;
LYMAN, CA ;
PIZZO, PA .
CLINICAL INFECTIOUS DISEASES, 1992, 14 :S139-S147
[38]   Influence of human serum on antifungal pharmacodynamics with Candida albicans [J].
Zhanel, GG ;
Saunders, DG ;
Hoban, DJ ;
Karlowsky, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2018-2022